chr3-37017508-C-T
Variant summary
The NM_000249.4(MLH1):c.793C>T (p.Arg265Cys) variant causes a missense, splice region change involving the alteration of a conserved nucleotide. The variant allele was found at a cumulative frequency of 0.000000684 (AC=1) in the gnomAD database across 1,461,428 control chromosomes (no homozygotes observed). The grpmax filtering allele frequency (95% CI) is 0.0000009. In-silico predictor (REVEL) classifies this variant as likely damaging/oncogenic. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. The affected nucleotide is highly conserved across species (PhyloP 100-way vertebrate score: 7.28). Variant has been reported in ClinVar as Pathogenic/Likely Pathogenic (★★★). ClinVar reports functional evidence for this variant: "SCV000262499: RNA analysis indicates that this missense change induces altered splicing and may result in an absent or altered protein product. Studies have shown that this missense change alters mRNA splicing and is expected to lead to the loss of protein expression (PMID:18561205, 22736432, 26247049" and additional evidence is available in ClinVar. A different missense at the same amino acid position has been reported as Pathogenic/Likely Pathogenic in ClinVar: p.R265V: Pathogenic (ClinVar VariationId 619508, 1 star) Other variants at the same amino acid position have been reported in ClinVar (not pathogenic): p.R265H: Conflicting_classifications_of_pathogenicity (ClinVar VariationId 90381, 1 star); p.R265L: Uncertain_significance (ClinVar VariationId 1928288, 2 stars); p.R265= (synonymous): Likely_benign (ClinVar VariationId 491730, 2 stars) This exact variant is established as oncogenic in: CGI (Cancer Genome Interpreter). This exact variant is curated in the UniProt human variants database as Uncertain Significance, associated with Colorectal cancer, hereditary nonpolyposis, type 2 (hnpcc2); it is also listed as a COSMIC curated somatic variant.
Frequency
Consequence
NM_000249.4 missense, splice_region
Predictors
Clinical Significance
Conservation
Publications
- Lynch syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P, ClinGen
- Lynch syndrome 2Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Ambry Genetics
- Muir-Torre syndromeInheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: G2P, Ambry Genetics, Genomics England PanelApp
- mismatch repair cancer syndrome 1Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
- Lynch syndrome 1Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- ovarian cancerInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
- malignant pancreatic neoplasmInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
- rhabdomyosarcomaInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
- prostate cancerInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- breast cancerInheritance: AD Classification: NO_KNOWN Submitted by: Ambry Genetics
- hereditary breast carcinomaInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
Classification according to ACMG Germline Pathogenicity v2019
Our verdict: Pathogenic. The variant received 24 points.
| Apply | Criterion Code & Title / Strength | Rationale / Clinical Context | |
|---|---|---|---|
| PS3Functional studies show damaging effect | Well-established functional study supports damaging effect (PS3); SCV000262499: RNA analysis indicates that this missense change induces altered splicing and may result in an absent or altered protein product. Studies have shown that this missense change alters mRNA splicing and is expected to lead to the loss of protein expression (PMID: 18561205, 22736432, 26247049; internal data).; SCV000276047: RNA studies have demonstrated that this alteration results in abnormal splicing in the set of samples tested (Ambry internal data).; SCV000279078: Published functional studies demonstrate a damaging effect: aberrant splicing and reduced mRNA and protein expression as well as deceased protein stability and reduced binding of MLH1 to PMS2 (PMID: 12386821, 15713769, 18205192, 20864636, 22753075, 21952876, 26761715); Observed in individuals with personal or family histories consistent with pathogenic variants in MLH1 and concordant tumor studies (PMID: 10495924, 12011148, 12386821, 12547705, 15849733, 15926618, 17312306, 19526325, 19698169, 19419416, 20045164, 20587412, 20682701, 21642682, 21404117, 21952876, 24710284, 26248088, 26202870, 30521064, 35534704); Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 17210669, 20020535, 18561205, 22824075, 20045164, 21404117, 20682701, 19224586, 21681552, 20864636, 28127413, 15731775, 21952876, 11781295, 11555625, 17594722, 22736432, 22949387, 22753075, 17135187, 23760103, 10495924, 16995940, 15849733, 12547705, 19698169, 26247049, 22843852, 24710284, 21642682, 16216036, 19526325, 20587412, 25345868, 17312306, 21155023, 26053027, 26248088, 17192056, 15926618, 12011148, 26202870, 23741719, 16830052, 15713769, 12386821, 17510385, 26761715, 25081409, 11948175, 28445943, 30274973, 31589614, 32849802, 31332305, 18205192, 33260537, 29758216, 24362816, 31447099, 30787465, 30521064, 31830689, 19419416, 35534704, 31391288, 40118241); SCV000592378: This variant has been tested in different functional assays at the protein level, with results that were not always consistent; the p.Arg265Cys was associated with a mild reduction of mismatch repair efficiency in four studies (Plotz 2006; Ellison 2001; Wanat 2007; Takahashi 2007) but not in a fifth one (Trojan 2002) (Tournier 2007).; SCV000684870: Functional studies have shown that this variant significantly decreases MLH1 protein stability (PMID: 18205192) and the ability of MLH1 protein to bind PMS2 (PMID: 21952876). This variant has also been shown to affect mRNA splicing (PMID: 12386821, 15713769, 18561205).; (+6 more) | ||
| PS4Prevalence increased in affected individuals | Rare variant reported in affected individuals by ≥2 independent ClinVar submitters (PS4_Supporting); 11 ClinVar submitter(s) report the variant in affected individuals; SCV000043791: In affected members of 13 Taiwanese families with hereditary nonpolyposis colorectal cancer (LYNCH2; 609310), Tang et al.; SCV000262499: This missense change has been observed in individual(s) with colorectal cancer or Lynch syndrome (PMID: 12386821, 15713769, 19419416, 20587412, 20864636).; SCV000276047: This mutation has been identified in several individuals who met Amsterdam I/II criteria for Lynch syndrome (Trojan, 2002; Wolf, 2005; Woods, 2010; Hardt, 2011; Ambry internal data). In addition, this mutation has been identified in multiple probands whose Lynch syndrome-associated tumor demonstrated high microsatellite instability and/or loss of MLH1/PMS2 expression by immunohistochemistry (Li, 2020; Ambry internal data).; SCV000279078: Published functional studies demonstrate a damaging effect: aberrant splicing and reduced mRNA and protein expression as well as deceased protein stability and reduced binding of MLH1 to PMS2 (PMID: 12386821, 15713769, 18205192, 20864636, 22753075, 21952876, 26761715); Observed in individuals with personal or family histories consistent with pathogenic variants in MLH1 and concordant tumor studies (PMID: 10495924, 12011148, 12386821, 12547705, 15849733, 15926618, 17312306, 19526325, 19698169, 19419416, 20045164, 20587412, 20682701, 21642682, 21404117, 21952876, 24710284, 26248088, 26202870, 30521064, 35534704); Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 17210669, 20020535, 18561205, 22824075, 20045164, 21404117, 20682701, 19224586, 21681552, 20864636, 28127413, 15731775, 21952876, 11781295, 11555625, 17594722, 22736432, 22949387, 22753075, 17135187, 23760103, 10495924, 16995940, 15849733, 12547705, 19698169, 26247049, 22843852, 24710284, 21642682, 16216036, 19526325, 20587412, 25345868, 17312306, 21155023, 26053027, 26248088, 17192056, 15926618, 12011148, 26202870, 23741719, 16830052, 15713769, 12386821, 17510385, 26761715, 25081409, 11948175, 28445943, 30274973, 31589614, 32849802, 31332305, 18205192, 33260537, 29758216, 24362816, 31447099, 30787465, 30521064, 31830689, 19419416, 35534704, 31391288, 40118241); SCV000592378: One large study of Tawainese patients demonstrated that the p.Arg265Cys variant was identified in 13 out of 93 unrelated families. In total, 93 cancers were noted in these 13 families including 66 with cases of colon cancer, 6 cases of rectal cancer, 3 cases of endometrial cancer, 6 cases of gastric cancer, 1 case of ovarian cancer and 11 cases of other types of cancer (Tang 2009).; (+6 more) | ||
| PM1Mutational hot spot or critical domain | Missense neighbourhood hotspot (≥2 P/LP within ±8 AA, OR ≥ 5 vs. background) — PM1; In-domain: 0 pathogenic, 0 benign rare missense variants; ±8 AA neighbourhood: 3 pathogenic, 3 benign (OR vs. background: 5.0) | ||
| PM2Absent/extremely low in population databases | Very rare in gnomAD for AD/XL gene (popmax AF < threshold/10) — PM2; GnomAD popmax AF = 0.0000009 — very rare for AD+AR gene (base 0.0001, raised to 0.0005 by highest known P/LP ClinVar AF 0.000636) — PM2 moderate | ||
| PM5Novel missense at known pathogenic residue | Different pathogenic missense at same AA residue in ClinVar (PM5); ClinVar contains a germline Pathogenic/Likely Pathogenic entry at the same amino acid position with a different amino acid change: p.R265V: Pathogenic (ClinVar VariationId 619508, 1 star); Other variants at the same amino acid residue (not pathogenic): p.R265H: Conflicting_classifications_of_pathogenicity (ClinVar VariationId 90381, 1 star); p.R265L: Uncertain_significance (ClinVar VariationId 1928288, 2 stars); p.R265= (synonymous): Likely_benign (ClinVar VariationId 491730, 2 stars) | ||
| PP1Cosegregation with disease | ClinVar submission reports cosegregation with disease (PP1); SCV000262499: It has also been observed to segregate with disease in related individuals.; SCV000276047: This mutation has also been shown to segregate with disease in several families meeting Amsterdam I/II criteria (De Jong, 2004; Tang, 2009; Sjursen, 2010).; SCV000731294: It segregated with disease in at least 12 family members (Hardt 2011, Tang 2009).; SCV004176523: This variant has been observed to segregate with disease (Tang R, et. al., 2009). | ||
| PP3Computational evidence supports damaging effect | Germline meta computational scorer (REVEL/MetaRNN/BayesDel) predicts damaging effect — strong evidence (PP3); Splicing verdict: not pathogenic; Germline computational verdict: pathogenic (Strong) | ||
| PP5Reputable source reports pathogenic | ClinVar ≥3 stars pathogenic — very strong (PP5); ClinVar submissions overwhelmingly pathogenic (≥10 total, ≥80% P/LP, <10% B/LB) — strong (PP5, count-based); ClinVar germline classification: Pathogenic/Likely Pathogenic, 3 star(s). ClinVar submissions strongly and reliably favor pathogenicity (24/25 total P/LP) |
Variant Effect in Transcripts
Automated classification analysis was done for transcript: NM_000249.4. You can select a different transcript below to see updated classification assignments.
RefSeq Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
MLH1 | MANE Select | c.793C>T p.Arg265Cys | missensesplice_region | Exon 10 of 19 | Prot: NP_000240.1 | |
MLH1 | c.793C>T p.Arg265Cys | missensesplice_region | Exon 10 of 18 | Prot: NP_001341557.1 | ||
MLH1 | c.694C>T p.Arg232Cys | missensesplice_region | Exon 9 of 18 | Prot: NP_001341558.1 |
Ensembl Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
MLH1 | MANE Select | c.793C>T p.Arg265Cys | missensesplice_region | Exon 10 of 19 | Prot: ENSP00000231790 | |
MLH1 | TSL:1 | c.70C>T p.Arg24Cys | missensesplice_region | Exon 11 of 20 | Prot: ENSP00000402667 | |
MLH1 | c.793C>T p.Arg265Cys | missensesplice_region | Exon 10 of 19 | Prot: ENSP00000601248 |
Frequencies
Allele frequencies (AF), counts (AC/AN), homozygotes and coverage
| Source / population | AF | AC | Hom | AN | Coverage |
|---|---|---|---|---|---|
Global population databases 5 sources | |||||
GnomAD3 genomes | Cov:32 | ||||
GnomAD4 exome | AF: 6.84e-7 | AC:1 | Hom:0 | AN:1461428 | Cov:31 |
GnomAD4 genome | Cov:32 | ||||
TOPMed (Bravo) | AF: 0.00000378 | AC:1 | Hom:0 | AN:264690 | |
ALFA (dbGaP/dbSNP Allele Frequency Aggregator) | AF: 0.0000175 | AC:1 | Hom:0 | AN:57126 | |
Case/control cohorts
| Cohort | Cases | Controls | ||||
|---|---|---|---|---|---|---|
| AF | AC | AN | AF | AC | AN | |
Epi25 | 0.0000238 | 1 | 41956 | 0.00 | 0 | 66876 |
SCHEMA | 0.00 | 0 | 48008 | 0.0000135 | 1 | 73916 |
ClinVar
Computational Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
AlphaGenome AVI | Pathogenic | 35 | |
AlphaMissense | Pathogenic | 0.99 | |
BayesDel_addAF | Pathogenic | 0.57 | D |
BayesDel_noAF | Pathogenic | 0.59 | |
CADD | Pathogenic | 33 | |
DANN | Pathogenic | 1.0 | |
DEOGEN2 | Pathogenic | 0.90 | D |
Eigen | Pathogenic | 1.1 | |
Eigen_PC | Pathogenic | 1.0 | |
FATHMM_MKL | Pathogenic | 1.0 | D |
FuncVEP CTI | Pathogenic | 1.0 | |
GPN-Star LLR | N/A | -8.5 | |
GPN-Star score | N/A | 8.5 | |
LIST_S2 | Pathogenic | 0.99 | D |
M_CAP | Pathogenic | 0.72 | D |
MetaRNN | Pathogenic | 0.99 | D |
MetaSVM | Pathogenic | 0.94 | D |
Mutation Taster | N/A | 0/100 | disease causing (ClinVar) |
MutationAssessor | Pathogenic | 4.8 | H |
PhyloP100 | Uncertain | 7.3 | |
popEVE | Benign | -4.0 | |
PrimateAI | Uncertain | 0.72 | T |
PROVEAN | Pathogenic | -7.8 | D |
RBP_binding_hub_radar | N/A | 0.0 | |
RBP_regulation_power_radar | N/A | 1.7 | |
REVEL | Pathogenic | 0.97 | |
Sift | Pathogenic | 0.0 | D |
Sift4G | Pathogenic | 0.0 | D |
Varity_R | N/A | 0.96 | |
VESM-3B | Benign | -12 |
Splicing Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
Pangolin (max) | Uncertain | 0.34 | |
Pangolin loss | Uncertain | 0.34 | Position offset: -2 |
SpliceAI score (max) | Benign | 0.15 | Details are displayed if max score is > 0.2 |
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.